Amgen Inc. v. F. Hoffmann-LaRoche LTD et al

Filing 1377

MOTION for Leave to File A Reply to Roche's Opposition to Amgen's Bench Memorandum Regarding Evidence of Infringement of '349 Claim 7 by Amgen Inc.. (Attachments: #1 Exhibit A)(Gottfried, Michael)

Download PDF
Amgen Inc. v. F. Hoffmann-LaRoche LTD et al Doc. 1377 Case 1:05-cv-12237-WGY Document 1377 Filed 10/14/2007 Page 1 of 4 UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS ) ) ) Plaintiff, ) v. ) ) ) F. HOFFMANN-LAROCHE LTD., a Swiss Company, ROCHE DIAGNOSTICS ) ) GMBH, a German Company, and ) HOFFMANN LAROCHE INC., a New ) Jersey Corporation, ) ) Defendants. AMGEN, INC., Civil Action No. 05 CV 12237 WGY PLAINTIFF AMGEN INC.'S MOTION FOR LEAVE TO FILE A REPLY TO ROCHE'S OPPOSITION TO AMGEN'S BENCH MEMORANDUM REGARDING EVIDENCE OF INFRINGEMENT OF `349 CLAIM 7 Amgen respectfully requests leave to file a Reply to Roche's Opposition to Amgen's Bench Memorandum Regarding Evidence of Infringement of `349 Claim 7.1 As grounds for this request, Amgen states that a reply is necessary to address certain arguments raised by Roche in its Opposition. Specifically, a reply is necessary to demonstrate that, contrary to the attorney argument that forms the sole basis for Roche's Opposition, Dr. Lodish's testimony and Roche's own documents provide three separate and sufficient bases for a finding of infringement of `349 claim 7: 1. Dr. Lodish's opinion that Roche's cells are capable upon growth in culture of producing EPO in excess of 100 U per 106 cells in 48 hours based upon his review of and reliance upon radioimmunoassay tests performed by Dr. McLawhon on Roche's cells grown in culture by Dr. Kolodner.2 1 2 A copy of Amgen's Proposed Reply is attached hereto as Exhibit A. Trial Tr. 2452:19 ­ 2455:11. DM1\1206849.1 Dockets.Justia.com Case 1:05-cv-12237-WGY Document 1377 Filed 10/14/2007 Page 2 of 4 2. Dr. Lodish's calculation based on data reported in Roche's BLA (Ex. 52) that Roche's commercial cells produce "in round numbers 1,500 units of EPO per million cells in 48 hours." This calculation was based upon an ELISA assay reported in the BLA which Dr. Lodish described as "a similar assay" to a radioimmunoassay ­ "both assays use an antibody to EPO which binds specifically to EPO to measure how much EPO is in the culture fluid" ­ and the results "would be very similar, if not identical."3 3. Roche's BLA shows that Roche follows the teachings of Example 10 in Dr. Lin's patents to make the EPO component of peg-EPO. Using these steps, the same cells described in Dr. Lin's Example 10 produced EPO well in excess of the production levels recited in the `349 claims.4 Since Roche follows these same steps, it would be more than reasonable for the jury to conclude that Roche's cells are capable of achieving the same "high level of expression of EPO" as Dr. Lin's cells. Based on the foregoing, Amgen submits that a brief reply is necessary to more fully address the foregoing and will aid the Court in deciding this matter. 3 4 Trial Tr. 2449:23 -2451:15. Trial Ex. 1, Col. 26, lines 43 ­ 65; Col. 28, lines 6-10. 2 DM1\1206849.1 Case 1:05-cv-12237-WGY Document 1377 Filed 10/14/2007 Page 3 of 4 Dated: October 14, 2007 Respectfully Submitted, AMGEN INC., By its attorneys, /s/ Michael R. Gottfried D. DENNIS ALLEGRETTI (BBO#545511) MICHAEL R. GOTTFRIED (BBO#542156) PATRICIA R. RICH (BBO#640578) DUANE MORRIS LLP 470 Atlantic Avenue, Suite 500 Boston, MA 02210 Telephone: (857) 488-4200 Facsimile: (857) 488-4201 LLOYD R. DAY, JR DAY CASEBEER MADRID & BATCHELDER LLP 20300 Stevens Creek Boulevard, Suite 400 Cupertino, CA 95014 Telephone: (408) 873-0110 Facsimile: (408) 873-0220 WILLIAM GAEDE III McDERMOTT WILL & EMERY 3150 Porter Drive Palo Alto, CA 94304 Telephone: (650) 813-5000 Facsimile: (650) 813-5100 KEVIN M. FLOWERS MARSHALL, GERSTEIN & BORUN LLP 233 South Wacker Drive 6300 Sears Tower Chicago IL 60606 Telephone: (312) 474-6300 Facsimile: (312) 474-0448 Of Counsel: STUART L. WATT WENDY A. WHITEFORD MONIQUE L. CORDRAY DARRELL G. DOTSON KIMBERLIN L. MORLEY ERICA S. OLSON AMGEN INC. One Amgen Center Drive Thousand Oaks, CA 91320-1889 (805) 447-5000 3 DM1\1206849.1 Case 1:05-cv-12237-WGY Document 1377 Filed 10/14/2007 Page 4 of 4 CERTIFICATE PURSUANT TO LOCAL RULE 7.1 I certify that counsel for the parties have conferred in an attempt to resolve or narrow the issues presented by this motion and no agreement was reached. /s/ Michael R. Gottfried Michael R. Gottfried CERTIFICATE OF SERVICE I hereby certify that this document, filed through the ECF system will be sent electronically to the registered participants as identified on the Notice of electronic filing and paper copies will be sent to those indicated as non-registered participants on October 14, 2007. /s/ Michael R. Gottfried Michael R. Gottfried 4 DM1\1206849.1

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?